A Phase II Study of Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2011
At a glance
- Drugs Tipifarnib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Oct 2005 New trial record.